Literature DB >> 11718495

Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacids.

M Zhu1, D E Nix, R D Adam, J M Childs, C A Peloquin.   

Abstract

STUDY
OBJECTIVES: To determine the effect of a high-fat meal, orange juice, and antacids on absorption of a single oral dose of cycloserine and to estimate its population pharmacokinetic parameters.
DESIGN: Randomized, four-period, crossover study.
SETTING: Clinical research center. PATIENTS: Twelve healthy volunteers.
INTERVENTIONS: Subjects received single doses of cycloserine 500 mg after a 12-hour fast (reference), with a high-fat meal, with orange juice, and with antacids. They also received clofazimine 200 mg, ethionamide 500 mg, and p-aminosalicylic acid granules 6000 mg.
MEASUREMENTS AND MAIN RESULTS: Plasma samples were collected for 48 hours and assayed by validated high-performance capillary electrophoresis assay. Concentration-time data were analyzed with noncompartmental, one-compartment, and population methods. The maximum concentration (Cmax) of cycloserine was decreased (p=0.02) by the high-fat meal. No other statistically significant differences were observed for Cmax and area under the curve from time zero to infinity across the four treatments. The high-fat meal significantly (p<0.0001) delayed time to maximum concentration by 4.7 times compared with that of the reference (1.1 hr).
CONCLUSION: The pharmacokinetics of cycloserine were minimally affected by orange juice and antacids, whereas the high-fat meal delayed absorption. Administering cycloserine without a high-fat meal avoids potential alterations in the pattern of absorption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11718495     DOI: 10.1592/phco.21.11.891.34524

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  21 in total

1.  Sleep-dependent declarative memory consolidation--unaffected after blocking NMDA or AMPA receptors but enhanced by NMDA coagonist D-cycloserine.

Authors:  Gordon B Feld; Tanja Lange; Steffen Gais; Jan Born
Journal:  Neuropsychopharmacology       Date:  2013-07-26       Impact factor: 7.853

Review 2.  Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.

Authors:  Stefan G Hofmann; Mark H Pollack; Michael W Otto
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

Review 3.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 4.  Therapeutic drug monitoring in the treatment of tuberculosis: an update.

Authors:  Abdullah Alsultan; Charles A Peloquin
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

5.  Pharmacokinetics of Second-Line Antituberculosis Drugs in Children with Multidrug-Resistant Tuberculosis in India.

Authors:  Agibothu Kupparam Hemanth Kumar; Alok Kumar; Thiruvengadam Kannan; Rakesh Bhatia; Dipti Agarwal; Santosh Kumar; Rajeshwar Dayal; Sheo Pratap Singh; Geetha Ramachandran
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 6.  Therapeutic drug monitoring in the treatment of tuberculosis.

Authors:  Charles A Peloquin
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Food-drug interactions.

Authors:  Rabia Bushra; Nousheen Aslam; Arshad Yar Khan
Journal:  Oman Med J       Date:  2011-03

8.  D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation.

Authors:  Elizabeth J Santa Ana; Bruce J Rounsaville; Tami L Frankforter; Charla Nich; Theresa Babuscio; James Poling; Kishorchandra Gonsai; Kevin P Hill; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2009-07-09       Impact factor: 4.492

Review 9.  Enhancing exposure-based therapy from a translational research perspective.

Authors:  Stefan G Hofmann
Journal:  Behav Res Ther       Date:  2007-06-17

Review 10.  Augmentation of Extinction and Inhibitory Learning in Anxiety and Trauma-Related Disorders.

Authors:  Lauren A M Lebois; Antonia V Seligowski; Jonathan D Wolff; Sarah B Hill; Kerry J Ressler
Journal:  Annu Rev Clin Psychol       Date:  2019-01-30       Impact factor: 18.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.